SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-07-040466
Filing Date
2007-05-16
Accepted
2007-05-16 11:34:48
Documents
11
Period of Report
2007-05-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a07-13858_28k.htm 8-K 23757
2 EX-99.1 a07-13858_2ex99d1.htm EX-99.1 16426
3 GRAPHIC g138582mai001.jpg GRAPHIC 46833
4 GRAPHIC g138582mai002.jpg GRAPHIC 141140
5 GRAPHIC g138582mai003.jpg GRAPHIC 47864
6 GRAPHIC g138582mai004.jpg GRAPHIC 57623
7 GRAPHIC g138582mai005.jpg GRAPHIC 49727
8 GRAPHIC g138582mai006.jpg GRAPHIC 43953
9 GRAPHIC g138582mai007.jpg GRAPHIC 56204
10 GRAPHIC g138582mai008.jpg GRAPHIC 64306
11 GRAPHIC g138582mai009.jpg GRAPHIC 45654
  Complete submission text file 0001104659-07-040466.txt   805338
Mailing Address ONE KENDALL SQUARE CAMBRIDGE MA 02139
Business Address ONE KENDALL SQ CAMBRIDGE MA 02139 6172527500
GENZYME CORP (Filer) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14680 | Film No.: 07856568
SIC: 2836 Biological Products, (No Diagnostic Substances)